US Stock MarketDetailed Quotes

RDY Dr Reddy's Laboratories Ltd

Watchlist
  • 80.900
  • +0.830+1.04%
Close Jul 23 16:00 ET
  • 80.900
  • 0.0000.00%
Post 16:23 ET
13.47BMarket Cap20.27P/E (TTM)

Dr Reddy's Laboratories Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
13.54%279.16B
12.49%70.83B
6.57%72.15B
9.11%68.8B
29.20%67.38B
14.69%245.88B
15.82%62.97B
27.26%67.7B
9.41%63.06B
6.02%52.15B
Operating revenue
13.54%279.16B
12.49%70.83B
6.57%72.15B
9.11%68.8B
29.20%67.38B
14.69%245.88B
15.82%62.97B
27.26%67.7B
9.41%63.06B
6.02%52.15B
Cost of revenue
8.47%115.56B
8.81%29.35B
8.47%29.95B
10.17%28.43B
6.44%27.83B
5.95%106.54B
5.25%26.97B
12.29%27.61B
-3.86%25.81B
11.29%26.15B
Gross profit
17.41%163.61B
15.24%41.48B
5.26%42.2B
8.38%40.37B
52.09%39.55B
22.40%139.34B
25.24%36B
40.13%40.09B
20.99%37.25B
1.19%26.01B
Operating expense
22.43%98.3B
22.96%28.21B
12.28%25.3B
8.94%22.88B
58.62%21.91B
3.04%80.29B
16.38%22.94B
16.40%22.53B
6.08%21.01B
-27.75%13.82B
Selling and administrative expenses
13.49%77.2B
13.81%20.48B
12.50%20.23B
13.50%18.8B
14.26%17.7B
9.58%68.03B
14.79%17.99B
16.68%17.98B
3.82%16.56B
2.98%15.49B
Research and development costs
18.02%22.87B
28.16%6.88B
15.43%5.57B
11.87%5.45B
15.24%4.98B
10.86%19.38B
24.04%5.37B
15.92%4.82B
9.10%4.87B
-4.61%4.33B
Other operating expenses
75.06%-1.78B
302.86%852M
-82.35%-496M
-221.28%-1.36B
87.14%-772M
-333.50%-7.12B
-44.33%-420M
-26.51%-272M
30.88%-423M
-1,210.70%-6B
Operating profit
10.59%65.31B
1.68%13.28B
-3.74%16.91B
7.66%17.49B
44.69%17.64B
64.41%59.05B
44.55%13.06B
89.73%17.56B
47.86%16.24B
85.33%12.19B
Net non-operating interest income expense
328.63%567M
-55.00%54M
230.34%189M
493.55%366M
67.69%-42M
-3,642.86%-248M
-86.03%120M
-408.51%-145M
-3,200.00%-93M
-912.50%-130M
Non-operating interest income
93.05%2.28B
36.50%647M
113.55%583M
232.87%719M
51.61%329M
22.28%1.18B
--474M
4.20%273M
-8.86%216M
3.83%217M
Non-operating interest expense
19.82%1.71B
67.51%593M
-5.74%394M
14.24%353M
6.92%371M
49.06%1.43B
--354M
94.42%418M
32.05%309M
79.79%347M
Other net income (expense)
284.05%6B
3,431.58%2.68B
208.40%1.16B
3,567.57%1.28B
-66.62%866M
143.03%1.56B
101.03%76M
-364.69%-1.07B
-102.18%-37M
212.15%2.59B
Gain on sale of security
10.51%3.43B
42.56%968M
12,800.00%774M
1,463.49%859M
-66.68%826M
46.83%3.1B
--679M
-97.52%6M
-119.94%-63M
289.78%2.48B
Earnings from equity interest
-60.27%147M
-53.95%35M
-55.00%27M
-70.00%42M
-54.26%43M
-47.37%370M
-27.62%76M
-67.57%60M
-43.32%140M
-43.37%94M
Special income (charges)
226.75%2.42B
347.57%1.68B
131.72%361M
435.09%382M
-114.29%-3M
70.36%-1.91B
90.96%-679M
-5,072.73%-1.14B
-110.08%-114M
-27.59%21M
-Less:Impairment of capital assets
-99.57%3M
-132.04%-173M
-17.91%110M
120.00%55M
--11M
-90.76%699M
-92.81%540M
185.11%134M
--25M
--0
-Less:Other special charges
---1.52B
----
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
174.32%900M
88.49%-16M
146.91%471M
591.01%437M
-61.90%8M
-208.22%-1.21B
---139M
-4,116.00%-1B
-107.87%-89M
-27.59%21M
Income before tax
19.06%71.87B
20.83%16.02B
11.69%18.26B
18.76%19.13B
25.98%18.46B
86.91%60.37B
433.83%13.26B
68.36%16.35B
27.05%16.11B
97.37%14.66B
Income tax
5.79%16.19B
-19.57%2.95B
15.30%4.47B
-13.02%4.33B
59.70%4.44B
75.26%15.3B
127.80%3.66B
46.56%3.88B
80.48%4.98B
61.85%2.78B
Net income
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
108.06%11.88B
Net income continuous Operations
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
108.06%11.88B
Minority interest income
Net income attributable to the parent company
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
108.06%11.88B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
108.06%11.88B
Basic earnings per share
23.29%334.65
36.11%78.66
10.28%82.81
31.99%88.96
17.94%84.4
91.04%271.43
996.08%57.79
76.35%75.09
12.71%67.4
107.78%71.56
Diluted earnings per share
23.32%334.02
36.15%78.53
10.31%82.68
32.73%88.78
17.96%84.22
91.16%270.85
996.58%57.68
76.44%74.95
12.14%66.89
107.92%71.4
Dividend per share
40.0259
0
0
0
40.0259
0
0
0
0
0
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue 13.54%279.16B12.49%70.83B6.57%72.15B9.11%68.8B29.20%67.38B14.69%245.88B15.82%62.97B27.26%67.7B9.41%63.06B6.02%52.15B
Operating revenue 13.54%279.16B12.49%70.83B6.57%72.15B9.11%68.8B29.20%67.38B14.69%245.88B15.82%62.97B27.26%67.7B9.41%63.06B6.02%52.15B
Cost of revenue 8.47%115.56B8.81%29.35B8.47%29.95B10.17%28.43B6.44%27.83B5.95%106.54B5.25%26.97B12.29%27.61B-3.86%25.81B11.29%26.15B
Gross profit 17.41%163.61B15.24%41.48B5.26%42.2B8.38%40.37B52.09%39.55B22.40%139.34B25.24%36B40.13%40.09B20.99%37.25B1.19%26.01B
Operating expense 22.43%98.3B22.96%28.21B12.28%25.3B8.94%22.88B58.62%21.91B3.04%80.29B16.38%22.94B16.40%22.53B6.08%21.01B-27.75%13.82B
Selling and administrative expenses 13.49%77.2B13.81%20.48B12.50%20.23B13.50%18.8B14.26%17.7B9.58%68.03B14.79%17.99B16.68%17.98B3.82%16.56B2.98%15.49B
Research and development costs 18.02%22.87B28.16%6.88B15.43%5.57B11.87%5.45B15.24%4.98B10.86%19.38B24.04%5.37B15.92%4.82B9.10%4.87B-4.61%4.33B
Other operating expenses 75.06%-1.78B302.86%852M-82.35%-496M-221.28%-1.36B87.14%-772M-333.50%-7.12B-44.33%-420M-26.51%-272M30.88%-423M-1,210.70%-6B
Operating profit 10.59%65.31B1.68%13.28B-3.74%16.91B7.66%17.49B44.69%17.64B64.41%59.05B44.55%13.06B89.73%17.56B47.86%16.24B85.33%12.19B
Net non-operating interest income expense 328.63%567M-55.00%54M230.34%189M493.55%366M67.69%-42M-3,642.86%-248M-86.03%120M-408.51%-145M-3,200.00%-93M-912.50%-130M
Non-operating interest income 93.05%2.28B36.50%647M113.55%583M232.87%719M51.61%329M22.28%1.18B--474M4.20%273M-8.86%216M3.83%217M
Non-operating interest expense 19.82%1.71B67.51%593M-5.74%394M14.24%353M6.92%371M49.06%1.43B--354M94.42%418M32.05%309M79.79%347M
Other net income (expense) 284.05%6B3,431.58%2.68B208.40%1.16B3,567.57%1.28B-66.62%866M143.03%1.56B101.03%76M-364.69%-1.07B-102.18%-37M212.15%2.59B
Gain on sale of security 10.51%3.43B42.56%968M12,800.00%774M1,463.49%859M-66.68%826M46.83%3.1B--679M-97.52%6M-119.94%-63M289.78%2.48B
Earnings from equity interest -60.27%147M-53.95%35M-55.00%27M-70.00%42M-54.26%43M-47.37%370M-27.62%76M-67.57%60M-43.32%140M-43.37%94M
Special income (charges) 226.75%2.42B347.57%1.68B131.72%361M435.09%382M-114.29%-3M70.36%-1.91B90.96%-679M-5,072.73%-1.14B-110.08%-114M-27.59%21M
-Less:Impairment of capital assets -99.57%3M-132.04%-173M-17.91%110M120.00%55M--11M-90.76%699M-92.81%540M185.11%134M--25M--0
-Less:Other special charges ---1.52B------------------------------------
-Gain on sale of property,plant,equipment 174.32%900M88.49%-16M146.91%471M591.01%437M-61.90%8M-208.22%-1.21B---139M-4,116.00%-1B-107.87%-89M-27.59%21M
Income before tax 19.06%71.87B20.83%16.02B11.69%18.26B18.76%19.13B25.98%18.46B86.91%60.37B433.83%13.26B68.36%16.35B27.05%16.11B97.37%14.66B
Income tax 5.79%16.19B-19.57%2.95B15.30%4.47B-13.02%4.33B59.70%4.44B75.26%15.3B127.80%3.66B46.56%3.88B80.48%4.98B61.85%2.78B
Net income 23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B108.06%11.88B
Net income continuous Operations 23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B108.06%11.88B
Minority interest income
Net income attributable to the parent company 23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B108.06%11.88B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B108.06%11.88B
Basic earnings per share 23.29%334.6536.11%78.6610.28%82.8131.99%88.9617.94%84.491.04%271.43996.08%57.7976.35%75.0912.71%67.4107.78%71.56
Diluted earnings per share 23.32%334.0236.15%78.5310.31%82.6832.73%88.7817.96%84.2291.16%270.85996.58%57.6876.44%74.9512.14%66.89107.92%71.4
Dividend per share 40.025900040.025900000
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cannabis
Cannabis
Intraday+0.13%